Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Other |
Adverse reactions |
Continuous assessment of adverse reactions (ARs) |
24-months Follow up, 60-months Follow-up |
|
Other |
Number of device deficiencies - trephine |
Number of device deficiencies - trephine |
24-months Follow up, 60-months Follow-up |
|
Other |
Number of device deficiencies - Application System |
Number of device deficiencies - Application System |
24-months Follow up, 60-months Follow-up |
|
Other |
Number of device deficiencies - number of product related issues |
Number of device deficiencies - number of product related issues |
24-months Follow up, 60-months Follow-up |
|
Primary |
Responder rate of overall KOOS |
The overall Knee injury and Osteoarthritis Outcome Score (KOOS5) responder rate defined as the proportion of patients with = 10 points improvement in the KOOS5 from baseline. |
24-months Follow-up |
|
Secondary |
Change of overall KOOS from baseline |
Change of overall KOOS from baseline to the 24-month assessment, Knee Injury and Osteoarthritis Outcome Score, score 0-100, higher score shows better outcome |
24-months Follow-up |
|
Secondary |
Change of the 5 sub-scores of the KOOS from baseline |
Change of the 5 sub-scores of the KOOS from baseline to the 24-month assessment, Knee Injury and Osteoarthritis Outcome Score, score 0-100, higher score shows better outcome |
24-months Follow-up |
|
Secondary |
Change of the IKDC subjective score from baseline |
Change from baseline to the 24-month visit in the IKDC subjective score, international knee documentation committee, score 0-100, higher score shows better outcome |
24-months Follow-up |
|
Secondary |
Change in the IKDC surgeon's part from baseline |
Change from baseline to the 24-month visit in the IKDC surgeon's part. international knee documentation committee, score 0-100, higher score shows better outcome |
24-months Follow-up |
|
Secondary |
MOCART (MRI imaging) |
In vivo performance measured by the assessment of the Magnetic Resonance, Observation of Cartilage Repair Tissue (MOCART) score, Magnetic Resonance Observation of Cartilage Repair Tissue, score 0-100, higher score shows better outcome |
24-months Follow-up |
|
Secondary |
IKDC subjective score responder rate |
IKDC subjective score responder rate, defined as the proportion of patients with > 20.5 points improvement in the IKDC subjective score from baseline to the 24-month visit |
24-months Follow-up |
|
Secondary |
Proportion of patients with treatment failure |
Proportion of patients with treatment failure |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Number of postop physical therapy |
Number of postop physical therapy |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Number of postop doctor visits |
Number of postop doctor visits |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Days of hospitalisation |
Days of hospitalisation |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Work/school status checklist |
Work/school status, changes due to injury in work or school status (pupil, worker full or part time, not working, job seeking) |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Days of work/school missed |
Days of work/school missed |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Patient satisfaction |
Patient questionnaire, 4 questions with 3 answer choices better, same, worse |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Treatment-related adverse reactions (ARs) |
Treatment-related adverse reactions (ARs) |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Rate of unplanned re-operations |
Rate of unplanned re-operations: all unplanned reoperations and those related to NOVOCART® Inject treatment |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Surgical time |
cut-to-suture time |
24-months Follow up, 60-months Follow-up |
|
Secondary |
Length of incision |
Length of incision |
24-months Follow up, 60-months Follow-up |
|